Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Remberger
Mats
M
Karolinska Institutet, Clinical Immunology, F79 Karolinska University Hospital, Huddinge, SE-141 86, Stockholm, Sweden. Mats.Remberger@labmed.ki.se
D006086:Graft vs Host Disease / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D018655:Lymphocyte Count; D011379:Prognosis; D012709:Serum Albumin / Q000096:biosynthesis; D013997:Time Factors; D014184:Transplantation, Homologous / Q000009:adverse effects*
D012709:Serum Albumin